481 related articles for article (PubMed ID: 23361255)
1. α-Synuclein and mitochondrial dysfunction in Parkinson's disease.
Mullin S; Schapira A
Mol Neurobiol; 2013 Apr; 47(2):587-97. PubMed ID: 23361255
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
3. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
[TBL] [Abstract][Full Text] [Related]
4. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
5. Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons.
Reeve AK; Ludtmann MH; Angelova PR; Simcox EM; Horrocks MH; Klenerman D; Gandhi S; Turnbull DM; Abramov AY
Cell Death Dis; 2015 Jul; 6(7):e1820. PubMed ID: 26181201
[TBL] [Abstract][Full Text] [Related]
6. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
7. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
[No Abstract] [Full Text] [Related]
8. The central theme of Parkinson's disease: α-synuclein.
Ozansoy M; Başak AN
Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
[TBL] [Abstract][Full Text] [Related]
9. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.
Inoue N; Ogura S; Kasai A; Nakazawa T; Ikeda K; Higashi S; Isotani A; Baba K; Mochizuki H; Fujimura H; Ago Y; Hayata-Takano A; Seiriki K; Shintani Y; Shintani N; Hashimoto H
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29371327
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.
Melo TQ; Copray SJCVM; Ferrari MFR
Neurochem Res; 2018 Dec; 43(12):2212-2223. PubMed ID: 30370500
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
Onyango IG
Neurochem Res; 2008 Mar; 33(3):589-97. PubMed ID: 17940895
[TBL] [Abstract][Full Text] [Related]
13. Interaction of α-Synuclein with ATP Synthase: Switching Role from Physiological to Pathological.
Tripathi T; Chattopadhyay K
ACS Chem Neurosci; 2019 Jan; 10(1):16-17. PubMed ID: 30133256
[TBL] [Abstract][Full Text] [Related]
14. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
[TBL] [Abstract][Full Text] [Related]
15. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in Parkinson's disease.
Zhu J; Chu CT
J Alzheimers Dis; 2010; 20 Suppl 2():S325-34. PubMed ID: 20442495
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Pozo Devoto VM; Falzone TL
Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
[TBL] [Abstract][Full Text] [Related]
18. Modulation of alpha-synuclein aggregation by dopamine: a review.
Leong SL; Cappai R; Barnham KJ; Pham CL
Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
[TBL] [Abstract][Full Text] [Related]
19. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
20. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
Abou-Sleiman PM; Muqit MM; Wood NW
Nat Rev Neurosci; 2006 Mar; 7(3):207-19. PubMed ID: 16495942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
